COVID-19 and autism
The current pandemic of Covid-19 has created a paradigm for possibly gaining greater insight in two conditions: 1) Inflammatory maladies in pregnancy, and. 2) The biology of IGF-1 in autism. Studies since the beginning of this century have supported the view that IGF-1 deficiency in the neonate defi...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12108
- Acceso en línea:
- https://doi.org/10.1016/j.mehy.2020.109797
http://hdl.handle.net/20.500.12010/12108
- Palabra clave:
- COVID-19
Autism
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido
| Summary: | The current pandemic of Covid-19 has created a paradigm for possibly gaining greater insight in two conditions: 1) Inflammatory maladies in pregnancy, and. 2) The biology of IGF-1 in autism. Studies since the beginning of this century have supported the view that IGF-1 deficiency in the neonate defines the basis of autism. As a result, it appears that interleukin-6 in corona virus-based infections causes reduced defenses because of suppressed IGF-1, especially in older patients. This may also portend an increase of autism in the offspring of gravidas currently affected severely by Covid-19. |
|---|